Top Biotech Picks For 2021 With The Most Upside Potential
In a new research report, Stifel identifies its 2021 picks from the biotech sector – and today’s article highlights the five Buy-rated stocks from that…
In a new research report, Stifel identifies its 2021 picks from the biotech sector – and today’s article highlights the five Buy-rated stocks from that…
“Many investors, especially more aggressive traders, look at lower-priced stocks as a way to not only make some good money but to get a higher…
A slew of biotech companies studying blood disease treatments presented data this past weekend at the annual American Society of Hematology (ASH) meeting – and,…
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
Companies involved in spectroscopy, bioelectronic medicine and telemedicine make up the three new biotech stocks to watch highlighted in today’s article, which also highlights new…
With the COVID-19 pandemic resulting in reduced doctor visits and delayed surgeries and procedures, many healthcare stocks have suffered this year. But as things begin…
While President Trump still refuses to concede and control of the Senate is still technically to be determined, a Biden presidency come January 20th appears…
For bullish biotech investors looking for a way to play the sector well into 2021, today’s article highlights an ETF to consider for that purpose,…
From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks…
From the country’s strategy for tackling COVID-19 to U.S.-China tensions to government regulations, some key changes can be expected under the coming Biden administration. At…